Cellect Announces Stem Cell Triumph – Nasdaq
CNA Finance (press release) |
Cellect Announces Stem Cell Triumph
Nasdaq (RTTNews.com) – The shares of Cellect Biotechnology Ltd. ( APOP ) surged in the pre-market as it unveiled the stem cell technology breakthrough with hundred percent acceptance. Thursday, the company said its ApoGraft Stem Cell transplant has zero … Cellect Bio's ApoGraft stem cells completely accepted by first blood cancer patients in Phase 1/2 study; shares up … Cellect (APOP) Says First Group of Patients in Clinical Trial With its ApoGraft Stem Cell Transplant Follow up … Cellect Biotechnology (APOP) Stock: Gaining On Stem Cell Breakthrough |
